Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma : a subgroup analysis of a phase 2 study

Bibliographic description

punktacja MNiSW [2017 A]: 40

title:	Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma : a subgroup analysis of a phase 2 study
author:	Salles Gilles, Schuster Stephen J., de Vos Sven, Wagner-Johnston Nina D., Viardot Andreas, Blum Kristie A., Flowers Christopher R., Jurczak Wojciech , Flinn Ian W., Kahl Brad S., Martin Peter, Kim Yeonhee, Shreay Sanatan, Will Matthias, Sorensen Bess, Breuleux Madlaina, Zinzani Pier Luigi, Gopal Ajay K.
journal title:	Haematologica
volume:	102
issue:	4
date of publication :	2017
pages:	e156-e159
ISSN:	0390-6078
eISSN:	1592-8721
DOI:	10.3324/haematol.2016.151738
language:	English
journal language:	English
departmental parameterization:	40
affiliation:	Wydział Lekarski : Klinika Hematologii
type:	journal article
subtype:	academic paper